These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 2994576)
1. [A phase II study of oral VP-16 in primary lung cancer]. Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576 [TBL] [Abstract][Full Text] [Related]
2. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group]. Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282 [TBL] [Abstract][Full Text] [Related]
3. [A phase II study of NK171 (etoposide)]. Kimura K; Niitani H Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442 [TBL] [Abstract][Full Text] [Related]
4. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung]. Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671 [TBL] [Abstract][Full Text] [Related]
5. [Effects of oral etoposide in small cell carcinoma of the lung]. Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103 [TBL] [Abstract][Full Text] [Related]
6. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration]. Furuse K Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of VP-16-213 in non-small-cell lung cancer. Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137 [TBL] [Abstract][Full Text] [Related]
8. [Phase I study of an oral administration of VP 16-213]. Ogawa M; Ota K; Oyama A; Fukuoka M; Takada M; Yoshida S; Sanpi K; Kimura I; Ohnoshi T; Kuraishi Y Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102 [TBL] [Abstract][Full Text] [Related]
9. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas]. Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122 [TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213]. Joss R; Goldhirsch A; Cavalli F; Weber W; Kaplan S; Obrecht JP; Sonntag R; Brunner KW Schweiz Med Wochenschr; 1981 Sep; 111(36):1331-4. PubMed ID: 7197802 [TBL] [Abstract][Full Text] [Related]
11. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. Ikeda M; Noda K; Hiura M; Tamaya T; Ozaki M; Hatae M; Ozawa M; Yamabe T; Tanaka K; Izumi R; Okada H; Ogita Y; Hoshiai H Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082 [TBL] [Abstract][Full Text] [Related]
12. [Phase II study of VP-16 (capsule) in solid tumors. A cooperative study]. Honma T; Ogawa M; Yoshida S; Meguro S; Hirano M; Hoshino A; Shirakawa S; Nakamura T; Fukuoka M; Toki H Gan To Kagaku Ryoho; 1985 Feb; 12(2):309-13. PubMed ID: 2982332 [TBL] [Abstract][Full Text] [Related]
13. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group]. Suzuki K Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024 [TBL] [Abstract][Full Text] [Related]
14. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma. Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920 [TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694 [No Abstract] [Full Text] [Related]
16. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)]. Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986 [TBL] [Abstract][Full Text] [Related]
17. Multicenter Phase II trial of etoposide in refractory small cell lung cancer. Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617 [No Abstract] [Full Text] [Related]
18. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma]. Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665 [No Abstract] [Full Text] [Related]
19. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study]. Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666 [No Abstract] [Full Text] [Related]
20. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer]. Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]